AUTOIMMUNE DISEASES OF THE SKIN

[1]  N. Pelc,et al.  Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia , 1990 .

[2]  L. Diaz,et al.  Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. , 1992, The Journal of investigative dermatology.

[3]  M. Amagai,et al.  Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. , 1992, The Journal of clinical investigation.

[4]  J. Bystryn,et al.  Identification of cicatricial pemphigoid antigens. , 1992, Archives of dermatology.

[5]  J. Uitto,et al.  Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium. , 1991, The Journal of biological chemistry.

[6]  Masayuki Amagai,et al.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.

[7]  J. Uitto,et al.  Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. , 1991, The Journal of biological chemistry.

[8]  E. Bauer,et al.  Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Chandler,et al.  The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis. , 1991, The Journal of investigative dermatology.

[10]  J. Uitto,et al.  Bullous pemphigoid antigen (BPAG1): cDNA cloning and mapping of the gene to the short arm of human chromosome 6. , 1990, Genomics.

[11]  F. Wojnarowska,et al.  The association of bullous pemphigoid and malignant disease: a case control study , 1990, The British journal of dermatology.

[12]  W. Saunders,et al.  Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. , 1990, The Journal of clinical investigation.

[13]  K. V. Ratnam,et al.  Pemphigus Therapy with Oral Prednisolone Regimens A 5‐Year Study , 1990, International journal of dermatology.

[14]  J. Roujeau,et al.  Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. , 1990, The Journal of investigative dermatology.

[15]  E. Beutner,et al.  Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. , 1990, Journal of the American Academy of Dermatology.

[16]  J. Bonnetblanc,et al.  Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. , 1990, Clinical immunology and immunopathology.

[17]  J. Zone,et al.  Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. , 1990, The Journal of clinical investigation.

[18]  A. Rook,et al.  Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. , 1990, Annals of internal medicine.

[19]  W. Cunliffe,et al.  Clearing of epidermolysis bullosa acquisita with cyclosporine. , 1988, Journal of the American Academy of Dermatology.

[20]  G. Eklund,et al.  Pemphigoid and cancer. , 1990, Archives of dermatology.

[21]  A. Oranje,et al.  Pemphigoid in Children , 1989, Pediatric dermatology.

[22]  M. Sanders,et al.  Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis. , 1989, The Journal of investigative dermatology.

[23]  A. Nanda,et al.  Pemphigus in pregnancy. , 1989, American journal of obstetrics and gynecology.

[24]  N. Korman,et al.  Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. , 1989, The New England journal of medicine.

[25]  K. Yancey,et al.  Generation of C5-dependent bioactivity by tissue-bound anti-BMZ autoantibodies. , 1989, The Journal of investigative dermatology.

[26]  P. Millard,et al.  Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study. , 1989, The British journal of ophthalmology.

[27]  L. Diaz,et al.  Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. , 1989, The Journal of investigative dermatology.

[28]  H. Su,et al.  Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens. , 1989, Autoimmunity.

[29]  J. Stanley,et al.  A 230-kD basic protein is the major bullous pemphigoid antigen. , 1989, The Journal of investigative dermatology.

[30]  D. Roop,et al.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. , 1988, The Journal of clinical investigation.

[31]  V. Ruocco.  Plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris: a novelty or a reappraisal? , 1988, Archives of dermatology.

[32]  M. Black,et al.  Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. , 1988, Journal of the American Academy of Dermatology.

[33]  D. Woodley,et al.  Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. , 1988, The Journal of investigative dermatology.

[34]  Jean Kanitakis,et al.  Treatment of nine cases of pemphigus vulgaris with cyclosporine. , 1988, Journal of the American Academy of Dermatology.

[35]  J. Zone,et al.  Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. , 1988, The Journal of clinical investigation.

[36]  R. Burgeson,et al.  Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. , 1988, The Journal of clinical investigation.

[37]  P. Wright,et al.  Immunofluorescent studies in ocular cicatricial pemphigoid , 1988, The British journal of dermatology.

[38]  P. Millard,et al.  Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study , 1988, The British journal of dermatology.

[39]  C. Camisa.  Vesiculobullous systemic lupus erythematosus. A report of four cases. , 1988, Journal of the American Academy of Dermatology.

[40]  R. Hall.  Dietary management of dermatitis herpetiformis. , 1987, Archives of dermatology.

[41]  E. Beutner,et al.  Reticulin and endomysial antibodies in bullous diseases. Comparison of specificity and sensitivity. , 1987, Archives of dermatology.

[42]  E. Christophers,et al.  Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. , 1987, Archives of dermatology.

[43]  H. Sander,et al.  Treatment of epidermolysis bullosa acquisita with cyclosporine. , 1987, Journal of the American Academy of Dermatology.

[44]  K. Wolff,et al.  Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. , 1987, Journal of the American Academy of Dermatology.

[45]  J. Lang,et al.  Severe ocular involvement in a patient with epidermolysis bullosa acquisita. , 1987, Journal of the American Academy of Dermatology.

[46]  E. Grosshans,et al.  Gold and pemphigus vulgaris. , 1987, Dermatologica.

[47]  P. Merlob,et al.  Neonatal pemphigus vulgaris. , 1986, Pediatrics.

[48]  M. Furue,et al.  Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. , 1986, Journal of the American Academy of Dermatology.

[49]  L. Diaz,et al.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. , 1985, Journal of immunology.

[50]  N. Ling,et al.  Subclass distribution of IgG autoantibodies in bullous pemphigoid. , 1986, The Journal of investigative dermatology.

[51]  J. Saurat,et al.  Oral gold therapy (Auranofin) in pemphigus vulgaris. , 1986, Dermatologica.

[52]  Y. Takahashi,et al.  Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. , 1985, The Journal of investigative dermatology.

[53]  P. Vaigot,et al.  Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes. , 1985, The Journal of investigative dermatology.

[54]  J. Couchman,et al.  Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes. , 1985, The Journal of investigative dermatology.

[55]  Y. Takahashi,et al.  A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. , 1985, The Journal of investigative dermatology.

[56]  P. Wright,et al.  The relationship between linear IgA disease and benign mucous membrane pemphigoid , 1984, The British journal of dermatology.

[57]  A. Inman,et al.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. , 1984, The Journal of investigative dermatology.

[58]  A. Ahmed,et al.  Pemphigus erythematosus: Presentation of four cases and review of literature , 1984 .

[59]  C. Camisa,et al.  Vesiculobullous systemic lupus erythematosus , 1983 .

[60]  E. Beutner,et al.  IgA Class Endomysium Antibodies in Dermatitis Herpetiformis and Coeliac Disease a , 1983, Annals of the New York Academy of Sciences.

[61]  L. Fry,et al.  Gluten challenge in dermatitis herpetiformis. , 1983, The New England journal of medicine.

[62]  A. Sklavounou,et al.  Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases. , 1982, Oral surgery, oral medicine, and oral pathology.

[63]  L. Fry,et al.  Long term follow‐up of dermatitis herpetiformis with and without dietary gluten withdrawal , 1982, The British journal of dermatology.

[64]  B. Fox,et al.  Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. , 1982, Journal of the American Academy of Dermatology.

[65]  R. Briggaman,et al.  Bullous systemic lupus erythematosus. , 1982, Journal of the American Academy of Dermatology.

[66]  R. Hall,et al.  Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. , 1982, Annals of internal medicine.

[67]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[68]  J. Voorhees,et al.  Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. , 1981, The Journal of clinical investigation.

[69]  R. Marsden,et al.  Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings , 1981, The British journal of dermatology.

[70]  H. Roenigk,et al.  Epidermolysis bullosa acquisita. , 1981, Archives of dermatology.

[71]  E. Shevach,et al.  Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia , 1981, Cell.

[72]  R. Briggaman,et al.  Epidermolysis bullosa acquisita: ultrastructural and immunological studies. , 1981, The Journal of investigative dermatology.

[73]  D. Lewis,et al.  Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. , 1980, The Journal of investigative dermatology.

[74]  H. Pehamberger,et al.  Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone antibodies; in vitro studies. , 1980, The Journal of investigative dermatology.

[75]  R. Jordon,et al.  Pemphigus and bullous pemphigoid. , 1980, IMJ. Illinois medical journal.

[76]  R. Pearson,et al.  Pemphigus vegetans: its relationship to eosinophilic spongiosis and favorable response to dapsone. , 1980, Archives of dermatology.

[77]  M. Dahl.  EPIDERMOLYSIS BULLOSA ACQUISITA‐A SIGN OF CICATRICIAL PEMPHIGOID? , 1979, The British journal of dermatology.

[78]  W. F. Lever.  Pemphigus and pemphigoid: A review of the advances made since 1964 , 1979 .

[79]  R. Auerbach,et al.  Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. , 1979, Archives of dermatology.

[80]  W. F. Lever,et al.  Correlation of antibodies in skin and serum with disease severity in pemphigus. , 1979, Archives of dermatology.

[81]  J. Strauss,et al.  Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. , 1979, Archives of dermatology.

[82]  O. Braun-falco,et al.  Plasma exchange in the treatment of pemphigus vulgaris , 1979, The British journal of dermatology.

[83]  R. Nilsen,et al.  Acquired epidermolysis bullosa treated with a gold compound. , 1979, Acta dermato-venereologica.

[84]  H. Gilmore.  Early detection of pemphigus vulgaris. , 1978, Oral surgery, oral medicine, and oral pathology.

[85]  M. Fellner,et al.  Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris. , 1978, Archives of dermatology.

[86]  M. Foster,et al.  Benign mucous membrane pemphigoid (cicatricial mucosal pemphigoid): a reconsideration. , 1977, Oral surgery, oral medicine, and oral pathology.

[87]  W. F. Lever,et al.  Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. , 1977, Archives of dermatology.

[88]  R. Rogers,et al.  Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. , 1977, Mayo Clinic proceedings.

[89]  W. Strober,et al.  HLA-B8 and dermatitis herpetiformis in patients with IgA deposits in skin. , 1977, Archives of dermatology.

[90]  A. Ahmed,et al.  Bullous pemphigoid: clinical and serologic evaluation for associated malignant neoplasms. , 1977 .

[91]  W. Eaglstein,et al.  Management of pemphigus with gold compounds: a long-term follow-up report. , 1976, Archives of dermatology.

[92]  A. Schroeter,et al.  Bullous pemphigoid and associated malignant neoplasms. , 1975, Archives of dermatology.

[93]  D. Tuffanelli.  Cutaneous immunopathology: recent observations. , 1975, The Journal of investigative dermatology.

[94]  K. Wolff,et al.  Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. , 1975, The Journal of investigative dermatology.

[95]  W. F. Lever,et al.  Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report. , 1975, The Journal of investigative dermatology.

[96]  T. Tomasi,et al.  Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. , 1973, The Journal of clinical investigation.

[97]  W. Eaglstein,et al.  Gold sodium thiomalate treatment of pemphigus. , 1973, Archives of dermatology.

[98]  N. Day,et al.  The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. , 1973, The Journal of clinical investigation.

[99]  H. Roenigk,et al.  Pemphigus treatment with azathioprine. Clinical and immunologic correlation. , 1973, Archives of dermatology.

[100]  W. Lobitz,et al.  The enigma of bullous pemphigoid and dermatitis herpetiformis. , 1972, Archives of dermatology.

[101]  R. Jordon,et al.  Direct immunofluorescent studies of pemphigus and bullous pemphigoid. , 1971, Archives of dermatology.

[102]  H. Roenigk,et al.  Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. , 1971, Archives of dermatology.

[103]  J. B. Meer,et al.  GRANULAR DEPOSITS OF IMMUNOGLOBULINS IN THE SKIN OF PATIENTS WITH DERMATITIS HERPETIFORMIS. AN IMMUNOFLUORESCENT STUDY , 1969 .

[104]  E. Beutner,et al.  Basement zone antibodies in bullous pemphigoid. , 1967, JAMA.